In particular, SOD levels, but not the activity [114], were found to be elevated in the hippocampus and amygdala of AD patients [115], while a decrease in SOD, GPx, and CAT levels was found in the frontal and temporal cortex [116]. This evidence concerns the gene CAT and Alzheimer disease.